Genetic Implications for Newborn Screening for Phenylketonuria

Cruz, Felix de la; Koch, Richard

doi:10.1016/s0095-5108(05)70093-2

Cited by 7 publications

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Current Awareness

2001

Prenatal Diagnosis

View full text Add to dashboard Cite

In order to keep subscribers up‐to‐date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of prenatal diagnosis. Each bibliography is divided into 17 sections: 1 Books, Reviews & Symposia; 2 General Interest; 3 Normal Fetal Development; 4 Gametogenesis and Pre‐implantation Diagnosis; 5 First Trimester Diagnosis; 6 Second Trimester Diagnosis; 7 Fetal Diagnosis by Ultrasound and Other Imaging; 8 Maternal Screening; 9 Screening for Carriers of Genetic Abnormality; 10 Technological Developments; 11 Confined Placental Mosaicism and Uniparental Disomy; 12 Molecular Cytogenetics; 13 Fetal Cells in Maternal Circulation; 14 Fetal Therapy; 15 Psychosocial Aspects; 16 Epidemiology and Environmental Factors; 17 Developmental Pathology. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted

show abstract

Current Awareness

2001

Prenatal Diagnosis

View full text Add to dashboard Cite

show abstract

Screening for Neonatal Genetic Disorders

Williams¹

2006

When to Screen in Obstetrics and Gynecology

View full text Add to dashboard Cite

Future Directions

Evans¹,

Wapner²

2001

Clinics in Perinatology

View full text Add to dashboard Cite

With the continued explosion of genetic technology, the number of disorders amenable to screening is expanding geometrically. Historically, most genetic screening has been in the newborn period. Much more can be done for the fetus if genetic screening and diagnosis are accomplished early in the pregnancy rather than after birth. The principal requirements to make neonatal screening disorders possible in the first trimester center around those tests that can be one on a molecular basis, and the development of fetal cell isolation from the maternal circulation. Over the course of the next decade, it is likely that many of the tests currently performed in the newborn period will be accomplished in the early or mid-gestational period.

show abstract

Genetic Implications for Newborn Screening for Phenylketonuria

Cited by 7 publications

References 19 publications

Current Awareness

Current Awareness

Screening for Neonatal Genetic Disorders

Future Directions

Contact Info

Product

Resources

About